Collecting data on Medtronic spinal devices after surgery
Official title: The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction
Run by Medtronic Spinal and Biologics · NCT05856370 · Data updated 2026-11-12
This study is trying to see how well Medtronic spinal devices work and how safe they are for people after their surgery over the next two years.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Medtronic Spinal and Biologics Industry-sponsored |
| Locations | 29 sites (Tucson, Arizona and 28 other locations) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | May 2031 |
| Study ends | May 2031 |
| Registry record updated | August 17, 2026 |
| Trial ID | NCT05856370 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 and older who are scheduled to receive a Medtronic cranial or spinal device.
✕Probably not a fit
Patients currently enrolled in other concurrent trials that may affect the results of this study will not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study aims to gather performance and safety data for Medtronic devices used in cranial and spinal procedures. Participants will be enrolled and monitored postoperatively for up to 24 months to assess the effectiveness and safety of these devices in routine clinical care. The study will follow a structured follow-up schedule, ensuring comprehensive data collection aligned with standard practices.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of Medtronic spinal devices' safety and effectiveness, leading to improved patient outcomes.
How similar studies have gone: Other studies involving post-market surveillance of medical devices have shown success in providing valuable safety and performance data.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subject provides written informed consent per institution and/or geographical requirements. 2. Subject is intended to receive or be treated with an eligible Medtronic Cranial and Spinal Technology (CST) device(s) (see product appendices), used alone or in combination, for a cranial and/or spinal indication(s). 3. Subject is at least 18 years of age or minimum legal age as required by local regulations. 4. Subject agrees to complete all required assessments per the Schedule of Events. Exclusion Criteria: 1. Subject is currently enrolled or plans to enroll in concurrent drug/device/biologic trial(s) that may confound this trial's results per investigator assessment (i.e. no required intervention that could affect interpretation of all-around device safety and or performance). 2. Subject who is, or is expected to be, inaccessible for all required follow-up visits. 3. Subject with exclusion criteria required by local law. 4. Subject is considered vulnerable at the time of obtaining consent.
Where it's running
-
University of Arizona
Tucson, Arizona, United States Recruiting -
OrthoArkansas
Little Rock, Arkansas, United States Recruiting -
University of California Davis Medical Center
Sacramento, California, United States Recruiting -
University of California, San Francisco (UCSF)
San Francisco, California, United States Recruiting -
Indiana University School of Medicine
Bloomington, Indiana, United States Recruiting -
Indiana Spine Group
Carmel, Indiana, United States Recruiting
Show 23 more locations
-
The Orthopaedic Research Foundation (OrthoIndy)
Indianapolis, Indiana, United States Recruiting -
Norton Leatherman Spine Specialists
Louisville, Kentucky, United States Recruiting -
University of Maryland Medical Center
Baltimore, Maryland, United States Recruiting -
Michigan Orthopaedic & Spine Surgeons
Rochester Hills, Michigan, United States Recruiting -
University of Minnesota
Minneapolis, Minnesota, United States Recruiting -
Washington University School of Medicine
St Louis, Missouri, United States Recruiting -
Washington University School of Medicine
St Louis, Missouri, United States Recruiting -
Rutgers University Department of Neurosurgery
New Brunswick, New Jersey, United States Recruiting -
University at Buffalo
Buffalo, New York, United States Recruiting -
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States Recruiting -
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States Recruiting -
Rhode Island Hospital University Orthopedic
Providence, Rhode Island, United States Recruiting -
Tennessee Orthopaedic Alliance
Nashville, Tennessee, United States Recruiting -
American Neurospine Institute, PLLC
Frisco, Texas, United States Recruiting -
University of Virginia Health System
Charlottesville, Virginia, United States Recruiting -
Virginia Spine Institute
Reston, Virginia, United States Recruiting -
Centre Hospitalier Universitaire Dijon Bourgogne
Dijon, Bourgogne-Franche-Comté, France Recruiting -
Hôpital Roger Salengro
Lille, France Recruiting -
Charité - Universitätsmedizin Berlin
Berlin, Germany Recruiting -
Centro Hospitalar Universitário São João
Porto, Portugal Recruiting -
Hospital Vall D'Hebron
Barcelona, Spain Recruiting -
Kings College Hospital NHS Foundation Trust
London, United Kingdom Recruiting -
University of Pittsburgh Medical Center UPMC Presbyterian
Pittsburgh, Pennsylvania, United States Active not recruiting
Study contacts
- Study coordinator: Lauren Oien
- Email: lauren.k.oien@medtronic.com
- Phone: +17635268124
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PMCF look at METROSAN spinal systems and BONEGRAFT materials in adults after spine surgery
This PMCF study tests the safety and performance of METROSAN Titania spinal systems and Bonegraft materials in adults undergoing spinal fusion or stabilization in routine practice.
-
Two-Level Spinal Fusion for Disc Degeneration or Deformity: MDT-0123 compared with Autologous Bone Graft
This study tests MDT-0123 against the patient’s own bone graft to see which helps two-level spine fusion better in people with disc degeneration or spinal deformity.
-
Evaluation of 3D Digital Surgery in Traumatology
This study is testing if using 3D digital surgery tools can help patients with orthopedic conditions have better surgery outcomes and fewer complications compared to traditional methods.
-
Effects of Ferric Derisomaltose on Anemia After Spinal Surgery
This study is testing if an intravenous iron treatment can help adults recovering from spinal surgery feel better and fix their anemia faster than taking oral iron.
-
Registry for spine surgery outcomes
This study is collecting information from patients who have spine surgery to see how safe certain devices are and if they help reduce pain and improve daily life over time.
-
AI system for analyzing spinal deformities
This study is testing a new AI system that helps doctors better diagnose and understand spinal deformities by analyzing patient images.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.